biotech
biotech Articles
The July 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Published:
Last Updated:
Intra-Cellular saw its shares dip on Wednesday after the firm announced that the FDA has canceled a meeting scheduled for July 31 to discuss the New Drug Application for lumateperone for the...
Published:
Last Updated:
Jounce Therapeutics shares jumped on Wednesday after the company announced an update on its strategic collaboration with Celgene. This collaboration was originally established in July of 2016.
Published:
Last Updated:
Acadia Pharmaceuticals shares dropped on Tuesday after the firm announced results from its late-stage study for the treatment of adult schizophrenia patients.
Published:
Last Updated:
Biogen shares rose after itreleased better than expected second-quarter financial results before the markets opened on Tuesday.
Published:
Last Updated:
While this company is unknown by many investors, one analyst believes that this could be even better than a double-your-money call.
Published:
Last Updated:
AvroBio shares continued their run on Wednesday, despite the firm announcing that it would be conducting a secondary offering.
Published:
Last Updated:
Inovio Pharma shares dipped on Wednesday after the company said that it was taking measures to cut costs and its overall burn rate. When a company says it’s cutting costs one thing it can mean is...
Published:
Last Updated:
24/7 Wall St. has picked a few biotech standouts from Tuesday to highlight. We have included information about each company, as well as recent trading activity and the consensus analyst price target.
Published:
Last Updated:
Gilead and Galapagos each saw shares shoot up on Monday after the companies announced a new collaboration.
Published:
Last Updated:
Capricor Therapeutics shares more than doubled on Monday after the firm announced interim analysis for its Duchenne muscular dystrophy midstage trial.
Published:
Last Updated:
Alkermes shares made a handy gain on Monday after the firm announced that it would be expanding its New Drug Application for ALKS 3831 to encompass the treatment of bipolar I disorder in addition to...
Published:
Last Updated:
Hookipa Pharma is not a household name, or even well-known within the biotech industry, but it is making waves on Friday after the firm announced an update from the FDA.
Published:
Last Updated:
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The June 28 short interest data has been compared with the previous report, and short interest in most...
Published:
Last Updated:
President Trump lost ground with his efforts to force drug companies to list drug prices on TV ads, with the effort being blocked on free speech concerns.
Published:
Last Updated: